18F-BL40

N/A

Report date: 2025/11/20 11:38:04
NME

Base Information

Drug Name18F-BL40
Drug Alias Name[18F]BL4018F-BL40
ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionC-X-C motif chemokine receptor 4 modulators
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsWaldenstrom MacroglobulinemiaMultiple MyelomaLymphoma, Mantle-Cell +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBritish Columbia Cancer Agency
China Registration ClassN/A

Develop Information

Active CompaniesBritish Columbia Cancer Agency
Inactive CompaniesN/A
Active IndicationsWaldenstrom MacroglobulinemiaMultiple MyelomaLymphoma, Mantle-Cell +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A